Arlington Capital Partners Acquires Millstone Medical Outsourcing

Millstone Medical Outsourcing Acquires MycoScience

November 14, 2022

Healthcare Services

Millstone Medical Outsourcing, an Arlington Capital Partners portfolio company, has completed the acquisition of MycoScience, a Willington, Connecticut-based provider of medical device and pharmaceutical laboratory and environmental testing services. The acquisition adds advanced laboratory and regulatory testing capabilities to Millstone's post-manufacturing and aftermarket services, enabling more in-house testing, faster time to market, and expanded end-to-end offerings.

Millstone Medical Outsourcing Acquires Ethide Laboratories

November 14, 2022

Healthcare Services

Millstone Medical Outsourcing, an Arlington Capital Partners portfolio company, acquired Ethide Laboratories on November 14, 2022. The acquisition adds Ethide's regulatory testing capabilities (EO residual, microbiology, sterility, package integrity) to Millstone's post-manufacturing service offering, broadening testing services and customer footprint.

Arlington Capital Partners Acquires Majority Stake in Riverpoint Medical

June 27, 2019

Medical Devices

Arlington Capital Partners completed a majority growth investment in Riverpoint Medical, a Portland-based developer and manufacturer of advanced biomedical textile medical devices. The investment will support Riverpoint's plans to expand manufacturing capacity, accelerate product development across wound closure, sports medicine and animal health markets, and scale the business with existing management retaining material ownership.

Arlington Capital Partners Acquires TEAM Technologies

November 26, 2024

Medical Devices

Arlington Capital Partners has acquired TEAM Technologies, a Morristown, Tennessee–headquartered medical device manufacturer and strategic supply‑chain solutions provider, from Clearlake Capital Group for an undisclosed sum. Arlington plans to build on TEAM Tech’s vertically integrated manufacturing footprint and accelerate growth through organic investment and strategic add‑on M&A to strengthen healthcare supply chains and customer capabilities.

Artemis Capital Partners Acquires Millrock Technology

September 30, 2025

Medical Devices

Artemis Capital Partners, a Boston-based private equity firm, has acquired Millrock Technology Inc., a Kingston, New York manufacturer of lyophilization (freeze-drying) instrumentation and process development tools for the pharmaceutical, biotech, and diagnostics markets. Under Artemis’ ownership Millrock will continue to operate independently from its Kingston facility while Artemis invests to scale the company’s technical capabilities and global reach.

Arlington Capital Partners Makes Majority Investment in Afton Scientific

January 30, 2024

Pharmaceuticals

Arlington Capital Partners has made a majority investment in Afton Scientific, a Charlottesville-based CDMO specializing in sterile injectable drug manufacturing and related lab/packaging services. The partnership will support Afton's capacity growth and expansion of service offerings while founder and CEO Tom Thorpe remains a material shareholder and will continue to lead the company.